Efficacy of Albis for the Prevention of Gastric Mucosal Injury Concomitant with the Use of Low-Dose Aspirin: A Prospective, Randomized, Placebo-Controlled Study

BACKGROUND/AIMS: Long-term use of aspirin can be a risk factor of peptic ulcer diseases. The aim of this study was to evaluate the efficacy of Albis (Daewoong Pharmaceutical Co., Ltd.) for the prevention of gastric mucosal injury caused by aspirin. METHODS: Aspirin users were enrolled and randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sang Gyun, Kim, Nayoung, Shin, Sung Kwan, Sung, In Kyung, Hong, Su Jin, Park, Hyo-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Gastrointestinal Endoscopy 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398368/
https://www.ncbi.nlm.nih.gov/pubmed/27196736
http://dx.doi.org/10.5946/ce.2016.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398368/
https://www.ncbi.nlm.nih.gov/pubmed/27196736
http://dx.doi.org/10.5946/ce.2016.031

Ejemplares similares